Takayuki Okuji
Nagoya, 4668550, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Thyroid autoantibodies at baseline predict longer survival in non-small cell lung cancer patients treated with anti-programmed cell death-1 blockade: a prospective study.
Journal: Nagoya journal of medical science
Published: October 11, 2023
Anti-tumor effects of anti-programmed cell death-1 antibody treatment are attenuated in streptozotocin-induced diabetic mice.
Journal: Scientific reports
Published: November 17, 2022
Elevated TSH Level, TgAb, and Prior Use of Ramucirumab or TKIs as Risk Factors for Thyroid Dysfunction in PD-L1 Blockade.
Journal: The Journal of clinical endocrinology and metabolism
Published: June 01, 2022
Increased Risk of Thyroid Dysfunction by PD-1 and CTLA-4 Blockade in Patients Without Thyroid Autoantibodies at Baseline.
Journal: The Journal of clinical endocrinology and metabolism
Published: September 22, 2021
Anti-pituitary antibodies and susceptible human leukocyte antigen alleles as predictive biomarkers for pituitary dysfunction induced by immune checkpoint inhibitors.
Journal: Journal for immunotherapy of cancer
Published: April 13, 2021
Pituitary dysfunction induced by immune checkpoint inhibitors is associated with better overall survival in both malignant melanoma and non-small cell lung carcinoma: a prospective study.
Journal: Journal for immunotherapy of cancer
Published: May 26, 2020
CD4+ T cells are essential for the development of destructive thyroiditis induced by anti-PD-1 antibody in thyroglobulin-immunized mice.
Journal: Science translational medicine
Published: March 18, 2020
Flash glucose monitoring helps achieve better glycemic control than conventional self-monitoring of blood glucose in non-insulin-treated type 2 diabetes: a randomized controlled trial.
Journal: BMJ open diabetes research & care
Published: December 12, 2019
Anti-thyroid antibodies and thyroid echo pattern at baseline as risk factors for thyroid dysfunction induced by anti-programmed cell death-1 antibodies: a prospective study.
Journal: British journal of cancer
Published: September 21, 2019
Last Updated: 09/26/2026